Home Nyheter BioStock at Swiss Nordic Bio 2025

BioStock at Swiss Nordic Bio 2025

BioStock at Swiss Nordic Bio 2025

17 mars, 2025

Last week, the Swiss Nordic Bio 2025 conference in Zürich gathered investors, life science executives, and industry experts to foster strategic collaborations and investment opportunities between Nordic and Swiss life science companies. BioStock was on-site as a media partner to capture key discussions and industry trends.

Swiss Nordic Bio is an annual high-level partnering and investor conference connecting Nordic and Swiss life science companies with leading venture capitalists, industry executives, and other key stakeholders. The event focuses on fostering cross-border collaborations, investments, and business opportunities in biotech, medtech, and digital health. It is co-hosted by Business Sweden and Vator Securities.

Insight, Innovation, Networking

The conference was kicked off with a welcome address from representatives, including Kjersti Rødsmoen, Ambassador at the Royal Norwegian Embassy in Bern, and Jonas Ribbelöv, Vator Securities. The agenda featured keynote speeches on the impact of frequency sound, music, creativity on wellbeing, and quantum computing across the pharma value chain, delivered by experts. The conference also included a panel discussion with industry leaders, investor pitches by life science companies, and one-to-one matchmaking meetings to foster networking and collaboration.

Engaging discussions and insights

Throughout the day, the mingling space was buzzing with company representatives, investors, and industry experts. BioStock took the opportunity to talk to several of these, gaining firsthand insights into their innovations, goals and strategies. We also spoke with co-hosts Vator Securities and Business Sweden to discuss the event’s significance for Nordic-Swiss collaboration and investment trends.

See all the interviews below.

Interview: Christopher Bengtsson, Business Sweden

YouTube video

Interview: Jonas Ribbelöv, Vator Securities

YouTube video

Interview: Søren Bregenholt, CEO, Alligator Biosciences

YouTube video

Interview: Jeff Borcherding, CEO, Immunovia

YouTube video

Interview: Petter Segelman Lindqvist, CEO, Isofol Medical

YouTube video

Interview: Mario Gualano, Director, Q-linea

YouTube video

Interview: Thomas Feldthus, CEO, Saniona

YouTube video

Interview: Petter Björquist, CEO, VERIGRAFT

YouTube video

Interview: Lena Wikingsson, CEO, Dilafor

YouTube video

Interview: Ellen Rietmann Ahl, Swisscanto by ZKB Asset Management

YouTube video

Interview: Laura Chirica, CEO, Cellevate

YouTube video

Interview: Samuel Svensson, CEO, Neogap

YouTube video

Prenumerera på BioStocks nyhetsbrev

Dela gärna!